Unfolded on December 1-2. We are very psyched to announce that our annual Synthetic Biology and Gene Cell Therapy activities will now officially be open for registration!
At this year's event, we practically are gathering thought leaders, decision-makers, C-Suite executives, investors, academic researchers, entrepreneurs, and practitioners around from all corners of the globe in the synthetic biology community and advanced gene cell therapy society to share their insights and visions not only in the academic setting but industry trend updates.
Encapsulating this excitement, SynBio & GCT Summit will broadly dive into what's-on-the-horizon topics in science, emerging technologies, applications, and investment from top to bottom. On top of that, gene cell therapy vertically being a precise application in the realm of synthetic biology will largely be learned and discussed including mRNA therapy especially in this unprecedented times, on-hands in-vivo and ex-vivo gene editing, our first-ever CART product approved, gene therapeutics, immune therapies, bioprocessing & CMC, commercialization, and global competitive landscape and beyond over our two-day exciting program agenda.
Set your calendar at the 4th SynBio & Gene Cell Therapy Industrial Chain Forum today!
*Name in Alphabetical order
Member of the Chinese Academy of Sciences,
Director of Academic Board, Chinese Academy of Sciences Key Laboratory of Nucleic Acid Biology, Institute of Biophysics
Fellow of American Academy of Microbiology, Head of the State Key Laboratory of Microbial Metabolism in China, President of Chinese Society for Microbiology
Member of the Chinese Academy of Sciences, Chief Physician, Chief Professor and Doctoral Supervisor ,Southeast University
Member of the Chinese Academy of Engineering Director of Institute of Immunology, Dean of the school of Basic Medicine (USTC)
Ph.D., Prof., Member of Chinese Academy of Sciences,
Professor at the University of Chinese Academy of Sciences and the Chinese Academy of Medical Sciences,
Vice-President of the Genetics Society of China and the Chinese Society for Urban Science Research, Chairman and Co-founder of BGI
Member of the Chinese Academy of Sciences,
Professor at Tianjin University (Virtual)
Member of the Chinese Academy of Sciences, Molecular Microbiologist, Principal Investigator at CAS Center for Excellence in Molecular Plant Sciences, Head of Department of Microbiology and Immunology at School of Life Sciences Fudan University
Member of Australian Academy of Technology and Engineering
Professor, Program in Emerging Infectious Diseases, DukeNUS Medical School, Singapore
Executive Director, PREPARE (Programme for Research in Epidemic Preparedness and Responses), Singapore
Standing Deputy Director General at State Key Laboratory of Respiratory Diseases
Principal Investigator at Guangzhou Institutes of Biomedicine and Health, CAS
Founder of Tongxieyi Forum; Secretary General of Tongxieyi New Drug Elite Club; Chairman, PharmaSea
Chief Scientific Officer
Legend Biotech Corporation
Chief physician of Hematology Oncology Department ,
Nanjing Children's Hospital
Professor at Institute for Mathematical Sciences
Renmin Unversity of China
Senior Vice President
Global Issuer Services HKEX
Xiamen Chokhmah Biotech
Executive President, President of Global R&D & Chief Medical Officer, Fosun Pharma
Former President, DSM China
Stemirna Therapeutics Co., Ltd.
VP of Global R&D Center, GenScript Biotech Corporation
Partner, YuanBio Venture Capital
Principal Investigator at Bioland Laboratory, Principal Investigator at Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
Chairman, Sino Boundary Medical Innovation Fund
Head of PM & RA, GenScript ProBio
, Cathay Biotech
Zhuhai Gao Ling Equity Investment Management Co., Ltd.
Professor, Distinguished Principal Investigator at School of Life Sciences, Westlake University
Sino Biopharmaceutical Limited
Chief Scientist ,Chongqing Precision Biotech
Chief Operating Officer of GenScript Life Sciences Group GenScript Biotech Corporation
CEO of ANRICH CAPITAL
CEO of BC Asset Management Centre
Lilly Asia Ventures
Professor of National Key Laboratory of Medical Immunology
Founder & Chairman at Science Committee,
Executive Partner, GTJA Investment Group
§ Junfeng Wang
Managing Director, Legend Capital
General Secretary of China Union of Life Science Societies
Createrna Science & Technology
Former Director of the Division of Pharmacometrics, FDA Clinical Pharmacology
Darren Xiao, Managing Director
Co-Head of Pharmaceutical Team
SDIC Fund Management Co., Ltd.
Shi Hua Medicine Co., Ltd./XPrecision LLC
Adjunct Professor at Center for Synthetic & Systems Biology/CSO
Professor at School of Life Sciences
East China Normal University
Professor and Dean of the School of Life Sciences
Co-Founder & Chief Strategy Officer, ClinChoice; Foreign Member of Russian Academy of Engineering
Partner, Leader of Pharma & Biotech Team，CEC Capital
Professor/Director in Biotherapy Center &
Cancer Center, First Affiliated Hospital of Zhengzhou University
The SVP&CSO of Vcanbio Cell&Gene Engineering Corp.,Ltd
Founder of the AnlongMed/AnlongBio
Ben Zhao Ph.D.
Zhejiang Haichang Biotech Co., Ltd Founder
General Manager, Bestzyme Bio-engineering Co., Ltd.
Li Zhu, Ph.D.
Executive Director & Chief Strategy Officer,
GenScript Biotech Corporation
Sponsors and exhibitors at the SB&GCT 2021, we value your ROI and always are looking to partner with you closely to stage the top converging activities, so that your financial and resource input are smartly allocated.
Genscript Biotech Corporation
Jiangsu Biological Technology Association
Jiangsu Drug Research and Development Association
Jiangsu Institute of Immunology
JITRI-Biomedicine and Medical Device Industrial Technology Service Center
Tongxieyi New Drug Elite Club
Synthetic Biology Journal
China Biomedical Park Collaboration Alliance (CBPCA)
Nanjing Biomedical Industry Innovation Investment Promotion Association
Chinese Biopharmaceutical Association (CBA)
China Pharmaceutical Enterprises Association (CPEA)
At the heart of Gulou District, Shangri-La Nanjing provides a convenient and elegant respite from the bustling city.
Within about 10 minutes’ drive from Nanjing Railway Station and easy access to the Xin Jie Kou shopping center, the hotel offers sweeping views of the city and Xuanwu Lake.
Visit us at http://www.shangri-la.com/nanjing/shangrila/about/.
We are thrilled to bring the Best Rate Guarantee back to our valued delegates so that their time at the conference period can be largely allocated. Find below the hotel booking system to make your reservation simple and fast at the Shangri-La Nanjing. Happy meeting and staying!
GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy. For more information, visit www.genscript.com.